A recent Cochrane meta-analysis51 including 13 studies on 6000 participants (4 with mepolizumab, 4 with reslizumab, and 5 with benralizumab) helps the use of anti-IL-5 treatments as an adjunct to standard therapies in individuals with severe eosinophilic asthma and poor control on the basis that these treatments roughly halve the pace of asthma exacerbations with this human population

A recent Cochrane meta-analysis51 including 13 studies on 6000 participants (4 with mepolizumab, 4 with reslizumab, and 5 with benralizumab) helps the use of anti-IL-5 treatments as an adjunct to standard therapies in individuals with severe eosinophilic asthma and poor

2013

2013. Drug Administration. This study examined whether CLA could be used as a new therapy to reduce CT production, which, in turn, would decrease disease duration and intensity in cholera patients. CLA could be used in place of traditional antibiotics

We also demonstrate stable epigenetic remodeling of the locus and uncover transcriptome-wide differences that result from endogenous versus exogenous expression

We also demonstrate stable epigenetic remodeling of the locus and uncover transcriptome-wide differences that result from endogenous versus exogenous expression. controlling cell-fate decisions. without relinquishing their stemness, resulting in loss of engraftment capabilities (Montarras, 2005). Consequently, the generation of functional